Funded by Bazraa Foundation, Thalassemia Center distributes dasferal drugs to a number of patients

The thalassemia patients’ center this morning distributed dasferal iron to a number of patients with thalassemia and genetic blood.

The distribution of this drug comes with the support and funding of the Bazraa Development Foundation for patients with an irrigated iron ratio of 5000 to 10,000 ng / ml.

Dysphalal is considered to be one of the basic drugs available free of charge to patients.